Nortrel Tablet
FDA Label NDC 0555-9009

50 label sections · Submitted to the FDA by Teva Pharmaceuticals Usa, Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Teva Pharmaceuticals Usa, Inc. for the product Nortrel (NDC 0555-9009). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: cardiovascular risk associated with smoking, combined oral contraceptives, clinical pharmacology, indications and usage, contraindictions, warnings, a. myocardial infarction, b. thromboembolism, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.